Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Gabriel C Léger & Fadi Massoud. (2013) Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease. Expert Review of Clinical Pharmacology 6:4, pages 423-442.
Read now
Read now
Piera Sozio, Laura S Cerasa, Lisa Marinelli & Antonio Di Stefano. (2012) Transdermal donepezil on the treatment of Alzheimer’s disease. Neuropsychiatric Disease and Treatment 8, pages 361-368.
Read now
Read now
Antonio Di Stefano, Antonio Iannitelli, Sara Laserra & Piera Sozio. (2011) Drug delivery strategies for Alzheimer's disease treatment. Expert Opinion on Drug Delivery 8:5, pages 581-603.
Read now
Read now
Alberto Halabe Bucay. (2009) Donepezil (aricept) as a treatment for anorexia nervosa: a very feasible therapeutic possibility. Expert Opinion on Investigational Drugs 18:5, pages 569-571.
Read now
Read now
Shu-Feng Zhou, Jun-Ping Liu & Balram Chowbay. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:2, pages 89-295.
Read now
Read now
Heinz Reichmann & Tjalf Ziemssen. (2009) Treatment strategies for nonmotor manifestations of Parkinson's disease. Expert Opinion on Pharmacotherapy 10:5, pages 773-784.
Read now
Read now
Sandra A Jacobson & Marwan N Sabbagh. (2008) Donepezil: potential neuroprotective and disease-modifying effects. Expert Opinion on Drug Metabolism & Toxicology 4:10, pages 1363-1369.
Read now
Read now
Walter J Lukiw. (2008) Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD). Expert Opinion on Emerging Drugs 13:2, pages 255-271.
Read now
Read now
Articles from other publishers (57)
Jing-Jing Xu, Jiao Luo, Heng Xi, Jin-Bu Xu & Lin-Xi Wan. (2023) Palladium-catalyzed synthesis and anti-AD biological activity evaluation of N-aryl-debenzeyldonepezil analogues. Frontiers in Chemistry 11.
Crossref
Crossref
Ahmed M. Salem, Nada M. Mostafa, Eman Al‐Sayed, Iten M. Fawzy & Abdel Nasser B. Singab. (2023)
Insights into the Role of
Erythrina corallodendron
L. in Alzheimer's Disease:
in Vitro
and
in Silico
Approach
. Chemistry & Biodiversity 20:7.
Crossref
Crossref
Sanghee Choi, Wang-Seob Shim, Jiyoung Yoon, Doowon Choi, Eunseo Song, Yeo Jin Choi, Soo-Heui Paik & Kyung-Tae Lee. (2023) Method Development and Validation for the Simultaneous Quantitation of Pentoxifylline, Its Pharmacologically Active Metabolites, and Donepezil Using LC-MS/MS in Rat Plasma: Its Application to a Pharmacokinetic Study. Separations 10:5, pages 276.
Crossref
Crossref
Astik Kumar, Sachithra Thazhathuveedu Sudevan, Aathira Sujathan Nair, Ashutosh Kumar Singh, Sunil Kumar, Jobin Jose, Tapan Behl, Sabitha Mangalathillam, Bijo Mathew & Hoon Kim. (2023) Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer’s Disease. Brain Sciences 13:2, pages 213.
Crossref
Crossref
Shuainan Zheng, Long Pan, Jianguang Hou, Aimei Liao, Yinchen Hou, Guanghai Yu, Xiaoxiao Li, Yongjian Yuan, Yuqi Dong, Penghui Zhao, Jie Zhang, Zheyuan Hu, Ming Hui, Jian Cao & Ji-Hong Huang. (2022) The role of wheat embryo globulin nutrients in improving cognitive dysfunction in AD rats. Food & Function 13:19, pages 9856-9867.
Crossref
Crossref
Rouchan Ali, Ghanshyam Das Gupta & Pooja A. Chawla. (2022) Aducanumab: A new hope in Alzheimer's disease. Health Sciences Review 4, pages 100039.
Crossref
Crossref
Parham Pooladgar, Mehdi Sakhabakhsh, Arsia Taghva & Saeed Soleiman-Meigooni. (2022) Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases. Iranian Journal of Pharmaceutical Research 21:1.
Crossref
Crossref
Philippe Delbreil, Jean-Michel Rabanel, Xavier Banquy & Davide Brambilla. (2022) Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings. Advanced Drug Delivery Reviews 187, pages 114397.
Crossref
Crossref
Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez & Lucía Melguizo-Rodríguez. (2022) Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 14:6, pages 1117.
Crossref
Crossref
Keshireddy AnjiReddy & S. Karpagam Subramanian. (2022) A New Mode of Thinfilm and Nanofiber for Burst Release of the Drug for
Alzheimer Disease; A Complete Scenario from Dispersible Polymer to
Formulation Methodology. Mini-Reviews in Medicinal Chemistry 22:6, pages 949-966.
Crossref
Crossref
Yuan Li, Xiuzhen Sun, Jianqun Zhuang, Junzhi Wang & Chunqiang Yang. (2022) Donepezil ameliorates oxygen‑glucose deprivation/reoxygenation‑induced cardiac microvascular endothelial cell dysfunction through PARP1/NF‑κB signaling. Molecular Medicine Reports 25:4.
Crossref
Crossref
Wei Xiong, Xiaoqin Zhao, Qing Xu, Guihua Wei, Liudai Zhang, Yuqing Fan, Lingmiao Wen, Yanjun Liu, Tinglan Zhang, Li Zhang, Yan Tong, Qiaozhi Yin, Tian-e Zhang & Zhiyong Yan. (2022) Qisheng Wan formula ameliorates cognitive impairment of Alzheimer's disease rat via inflammation inhibition and intestinal microbiota regulation. Journal of Ethnopharmacology 282, pages 114598.
Crossref
Crossref
Lin-Xi Wan, Shi-Xing Miao, Zhen-Xiang He, Xiaohuan Li, Xian-Li Zhou & Feng Gao. (2021) Pd-Catalyzed Direct Modification of an Anti-Alzheimer’s Disease Drug: Synthesis and Biological Evaluation of α-Aryl Donepezil Analogues. ACS Omega 6:36, pages 23347-23354.
Crossref
Crossref
Ana CVV Giacomini, Barbara W Bueno, Leticia Marcon, Naiara Scolari, Rafael Genario, Konstantin A Demin, Tatyana O Kolesnikova, Allan V Kalueff & Murilo S de Abreu. (2020) An acetylcholinesterase inhibitor, donepezil, increases anxiety and cortisol levels in adult zebrafish. Journal of Psychopharmacology 34:12, pages 1449-1456.
Crossref
Crossref
Cindy Juliet Cristancho Ortiz, Caio Miranda Damasio, Letizia Pruccoli, Nathália Fonseca Nadur, Luciana Luiza de Azevedo, Isabella Alvim Guedes, Laurent Emmanuel Dardenne, Arthur Eugen Kümmerle, Andrea Tarozzi & Claudio ViegasJr.Jr.. (2020) Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases. Neurochemical Research 45:12, pages 3003-3020.
Crossref
Crossref
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide
243
248
.
Stephen M. Stahl. 2021. Prescriber's Guide. Prescriber's Guide.
Niloufar Choubdar & Sara Avizheh. (2020) Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease. Nanoscience & Nanotechnology-Asia 10:3, pages 228-247.
Crossref
Crossref
Kowthavarapu Venkata Krishna, Geetika Wadhwa, Amit Alexander, Neha Kanojia, Ranendra Narayan Saha, Ritushree Kukreti, Gautam Singhvi & Sunil Kumar Dubey. (2019) Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery. ACS Chemical Neuroscience 10:9, pages 4124-4135.
Crossref
Crossref
Pablo Zambrano, Mario Suwalsky, Malgorzata Jemiola-Rzeminska, Kazimierz Strzalka, Benjamin Sepúlveda, María J. Gallardo & Luis F. Aguilar. (2019) The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1861:6, pages 1078-1085.
Crossref
Crossref
James T. BrewsterIIII, Simone Dell’Acqua, Danny Q. Thach & Jonathan L. Sessler. (2018) Classics in Chemical Neuroscience: Donepezil. ACS Chemical Neuroscience 10:1, pages 155-167.
Crossref
Crossref
Jana Zdarova Karasova, Vit Sestak, Jan Korabecny, Eva Mezeiova, Vladimir Palicka, Kamil Kuca & Martin Mzik. (2018) 1-Benzyl-4-methylpiperidinyl moiety in donepezil: The priority ticket across the blood-brain-barrier in rats. Journal of Chromatography B 1092, pages 350-358.
Crossref
Crossref
Chang Yell Shin, Hae-Sun Kim, Kwang-Ho Cha, Dong Han Won, Ji-Yun Lee, Sun Woo Jang & Uy Dong Sohn. (2018) The Effects of Donepezil, an Acetylcholinesterase Inhibitor, on Impaired Learning and Memory in Rodents. Biomolecules & Therapeutics 26:3, pages 274-281.
Crossref
Crossref
Christopher WilkeDavid GrosshansJoseph DumanPaul BrownJing Li. (2018) Radiation-induced cognitive toxicity: pathophysiology and interventions to reduce toxicity in adults. Neuro-Oncology 20:5, pages 597-607.
Crossref
Crossref
Zhengping Zhang, Rong Chen, Wenji An, Chunmei Wang, Gaoyong Liao, Xiaoliang Dong, Aijing Bi, Zhimin Yin & Lan Luo. (2015) A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25–35-impaired mouse cognitive function. Psychopharmacology 233:4, pages 599-613.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
215
225
.
Chad M. VanDenBerg & Michael W. Jann. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
329
349
.
Sagar H. Barage & Kailas D. Sonawane. (2015) Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease. Neuropeptides 52, pages 1-18.
Crossref
Crossref
Maviye Galipoğlu, Meryem Sedef Erdal & Sevgi Güngör. (2014) Biopolymer-Based Transdermal Films of Donepezil as an Alternative Delivery Approach in Alzheimer’s Disease Treatment. AAPS PharmSciTech 16:2, pages 284-292.
Crossref
Crossref
Yoon-Sang Oh, Joong-Seok Kim, Dong Woo Ryu & Kwang-Soo Lee. (2012) Donepezil induced antecollis in a patient with Parkinson’s disease dementia. Neurological Sciences 34:9, pages 1685-1686.
Crossref
Crossref
Matthias Vandesquille, Mathieu Baudonnat, Laurence Decorte, Caroline Louis, Pierre Lestage & Daniel Béracochéa. (2013) Working memory deficits and related disinhibition of the cAMP/PKA/CREB are alleviated by prefrontal α4β2*-nAChRs stimulation in aged mice. Neurobiology of Aging 34:6, pages 1599-1609.
Crossref
Crossref
Kevin Ong & Michael Woodward. (2013) Non-English speaking background patients in a predominantly English-speaking region may be more likely to present with a dementia other than Alzheimer’s disease. Advances in Aging Research 02:03, pages 94-99.
Crossref
Crossref
Soad A Yehia, Ahmed H Elshafeey & Ibrahim Elsayed. (2012) Biodegradable donepezil lipospheres for depot injection: optimization and in-vivo evaluation. Journal of Pharmacy and Pharmacology 64:10, pages 1425-1437.
Crossref
Crossref
Ramakrishna Nirogi, Gopinadh Bhyrapuneni, Vishwottam Kandikere, Vijay Benade, Nageswararao Muddana, Ramanatha Saralaya, Shantaveer Irappanavar, Ranjithkumar Ponnamaneni & K. Mukkanti. (2012) Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats. European Journal of Drug Metabolism and Pharmacokinetics 37:3, pages 155-161.
Crossref
Crossref
M Vandesquille, I Carrié, C Louis, D Beracochea & P Lestage. (2011) Effects of positive modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors in a benzodiazepine-induced deficit of spatial discrimination in mice. Journal of Psychopharmacology 26:6, pages 845-856.
Crossref
Crossref
Joonho Choi, Min-Koo Choi, Saeho Chong, Suk-Jae Chung, Chang-Koo Shim & Dae-Duk Kim. (2012) Effect of fatty acids on the transdermal delivery of donepezil: In vitro and in vivo evaluation. International Journal of Pharmaceutics 422:1-2, pages 83-90.
Crossref
Crossref
Nathan Herrmann, Sarah A. Chau, Ida Kircanski & Krista L. Lanctôt. (2011) Current and Emerging Drug Treatment Options for Alzheimerʼs Disease. Drugs 71:15, pages 2031-2065.
Crossref
Crossref
Fadi Massoud & Gabriel C Léger. (2011) Pharmacological Treatment of Alzheimer Disease. The Canadian Journal of Psychiatry 56:10, pages 579-588.
Crossref
Crossref
Yanjing Bai, Chihiro Tohda, Shu Zhu, Masao Hattori & Katsuko Komatsu. (2011) Active components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25–35)-induced neuritic atrophy in cultured rat cortical neurons. Journal of Natural Medicines 65:3-4, pages 417-423.
Crossref
Crossref
Fadi Massoud, Julie Eve Desmarais & Serge Gauthier. (2010) Switching cholinesterase inhibitors in older adults with dementia. International Psychogeriatrics 23:3, pages 372-378.
Crossref
Crossref
Rüdiger Hardeland. (2011) Cognitive Enhancers in Moderate to Severe Alzheimer's Disease. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6344.
Crossref
Crossref
Takuya Urano & Chihiro Tohda. (2010) Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β‐induced neurite atrophy. Phytotherapy Research 24:11, pages 1658-1663.
Crossref
Crossref
Vesna JelicTaher Darreh-Shori. (2010) Donepezil: A Review of Pharmacological Characteristics and Role in the Management of Alzheimer Disease. Clinical Medicine Insights: Therapeutics 2, pages CMT.S5410.
Crossref
Crossref
Shu-Feng Zhou. (2009) Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance. Clinical Pharmacokinetics 48:12, pages 761-804.
Crossref
Crossref
Ebrahim Barzegari Asadabadi, Parviz Abdolmaleki, Seyyed Mohsen Hosseini Barkooie, Samad Jahandideh & Mohammad Ali Rezaei. (2009) A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase. Computers in Biology and Medicine 39:12, pages 1089-1095.
Crossref
Crossref
Woei-Shin Chen, Fong-Kuan Wong, Paul F. Chapman & Darrel J. Pemberton. (2009) Effect of donepezil on reversal learning in a touch screen-based operant task. Behavioural Pharmacology 20:7, pages 653-656.
Crossref
Crossref
Shinsui Kunitachi, Yuko Fujita, Tamaki Ishima, Mami Kohno, Mao Horio, Yuko Tanibuchi, Yukihiko Shirayama, Masaomi Iyo & Kenji Hashimoto. (2009) Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: Role of sigma-1 receptors. Brain Research 1279, pages 189-196.
Crossref
Crossref
Elena I. Solntseva, Julia V. Bukanova, Evgeny V. Marchenko, Alexey V. Rossokhin & Vladimir G. Skrebitsky. (2008) The Binding of Donepezil with External Mouth of K+-Channels of Molluscan Neurons. Cellular and Molecular Neurobiology 29:2, pages 219-224.
Crossref
Crossref
Chihiro Tohda, Rie Naito & Eri Joyashiki. (2008) Kihi-to, a herbal traditional medicine, improves Abeta(25–35)-induced memory impairment and losses of neurites and synapses. BMC Complementary and Alternative Medicine 8:1.
Crossref
Crossref
. (2009) Generika in der Psychiatrie; Tiroler Psychologiepreis geht an Schulpsychologen Dr. Hans Henzinger; Ein breites Spektrum für die individuelle Therapie; Konsequente Frühtherapie mit Interferon beta-1b verbessert Langzeitprognose bei multipler Sklerose. Psychopraxis 11:6, pages 40-42.
Crossref
Crossref
Elizabeth Thomas, Peter J. Snyder, Robert H. Pietrzak, Colleen E. Jackson, Martin Bednar & Paul Maruff. (2008) Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Neuropsychologia 46:10, pages 2476-2484.
Crossref
Crossref
Francesco Leonetti, Marco Catto, Orazio Nicolotti, Leonardo Pisani, Anna Cappa, Angela Stefanachi & Angelo Carotti. (2008) Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors. Bioorganic & Medicinal Chemistry 16:15, pages 7450-7456.
Crossref
Crossref
Debora Cutuli, Francesca Foti, Laura Mandolesi, Paola De Bartolo, Francesca Gelfo, Francesca Federico & Laura Petrosini. (2008) Cognitive performance of healthy young rats following chronic donepezil administration. Psychopharmacology 197:4, pages 661-673.
Crossref
Crossref
. (2008) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 23:2.
Crossref
Crossref
François Chast. 2008. The Practice of Medicinal Chemistry. The Practice of Medicinal Chemistry
1
62
.
Anke Sambeth, Wim J. Riedel, Laura Th. Smits & Arjan Blokland. (2007) Cholinergic drugs affect novel object recognition in rats: Relation with hippocampal EEG?. European Journal of Pharmacology 572:2-3, pages 151-159.
Crossref
Crossref
Ramesh C. Gupta & Andrzej Dekundy. (2007) Donepezil‐ or rivastigmine‐induced acetylcholinesterase inactivation is not modulated by neramexane in rat brain. Drug Development Research 68:5, pages 253-260.
Crossref
Crossref